Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...
Main Authors: | Sophie O’Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman |
---|---|
格式: | Article |
語言: | English |
出版: |
Nature Portfolio
2023-03-01
|
叢編: | Scientific Reports |
在線閱讀: | https://doi.org/10.1038/s41598-023-31055-3 |
相似書籍
-
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
由: Yoon-Jung Kang, et al.
出版: (2022-11-01) -
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
由: Simon Strohmeier, et al.
出版: (2021-05-01) -
NTRK fusion in Japanese colorectal adenocarcinomas
由: Yuya Yamashiro, et al.
出版: (2021-03-01) -
NTRK1 fusion in glioblastoma multiforme.
由: Jinkuk Kim, et al.
出版: (2014-01-01) -
<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
由: Heejin Bang, et al.
出版: (2022-06-01)